Interleukin-2 antisense oligonucleotides inhibit T-cell function
Stepkowski, S.M.; Tian, L.; Kloc, M.
Transplantation Proceedings 25(1 Part 1): 125
1993
ISSN/ISBN: 0041-1345 PMID: 8438248 Document Number: 416736
Document emailed within 1 workday
Related Documents
Sommer, W.; Heilig, M. 1999: Antisense oligonucleotides are clinically tested. they inhibit the expression of disease-related genes Lakartidningen 96(4): 348-354De Falco, S.; Boutorine, A.; de Smidt, C.; van Berkel, T.; Saison, E.; Hélène, C.; Le Doan, T. 1991: Utilization of antisense oligonucleotides in vivo: stability and internalization of hydrophobized oligonucleotides Nucleic Acids Symposium Series 24: 157-158
Vellón, L.; Cuello, T.; Gargallo, P.; Larripa, I. 2000: Antisense oligonucleotides increase the apoptotic effect of idarubicin in K-562 cell line Medicina 60(1): 143-145
Palubin, K.M.; Goodwin, B.L.; Niesen, M.I.; Le, E.A.; Osborne, A.R.; Blanck, G. 2006: A direct mechanistic link between growth control and a tumor cell immune function: increased interleukin-8 secretion accounts for elimination of Oct-1 antisense transformants from scid mice Anticancer Research 26(3a): 1733-1738
Gnarra, J.R.; Dressler, G.R. 1995: Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides Cancer Research 55(18): 4092-4098
Smetsers, T.F.; van de Locht, L.T.; Pennings, A.H.; Wessels, H.M.; de Witte, T.M.; Mensink, E.J. 1995: Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels Leukemia 9(1): 118-130
Chen, Z.; Fisher, R.J.; Riggs, C.W.; Rhim, J.S.; Lautenberger, J.A. 1997: Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides Cancer Research 57(10): 2013-2019
Guinot, P.; Temsamani, J. 1998: Antisense oligonucleotides: a new therapeutic approach Pathologie-Biologie 46(5): 347-354
Mazza, P. 1992: Therapeutic perspectives on antisense oligonucleotides Bollettino Chimico Farmaceutico 131(10): 355-362
Le Doan, T.; Etoré, F.; David, D.F.; Tenu, J.P. 1996: Prospects of a more selective chemotherapy with antisense oligonucleotides Annales de Medecine Interne 147(8): 542-552
Juliano, R.L.; Yoo, H. 2000: Aspects of the transport and delivery of antisense oligonucleotides Current Opinion in Molecular Therapeutics 2(3): 297-303
Ho, P.T.; Parkinson, D.R. 1997: Antisense oligonucleotides as therapeutics for malignant diseases Seminars in Oncology 24(2): 187-202
Uhlmann, E. 2000: Recent advances in the medicinal chemistry of antisense oligonucleotides Current Opinion in Drug Discovery and Development 3(2): 203-213
Kozlov, V.A.; Sennikov, S.V. 1997: The use of antisense oligonucleotides for modulation of cytokine gene expression Voprosy Meditsinskoi Khimii 43(5): 308-320
Barry, E.L.; Gesek, F.A.; Friedman, P.A. 1993: Introduction of antisense oligonucleotides into cells by permeabilization with streptolysin O Biotechniques 15(6): 1016-8 1020
Nakamura, T.Y.; Artman, M.; Rudy, B.; Coetzee, W.A. 1998: Inhibition of rat ventricular IK1 with antisense oligonucleotides targeted to Kir2.1 mRNA American Journal of Physiology 274(3): H892-H900
Sakamoto, H.; Sakamaki, T.; Kanda, T.; Hirao, Y.; Ohyama, Y.; Ogishi, K.; Negishi, M.; Masuda, H.; Sumino, H.; Sawada, Y.; Ono, Z.; Kobayashi, I.; Nagai, R. 1997: Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells Research Communications in Molecular Pathology and Pharmacology 97(1): 60-66
Keith, F.J.; Bradbury, D.A.; Zhu, Y.M.; Russell, N.H. 1995: Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C Leukemia 9(1): 131-138
Gao, B.-a.; Xiong, W.-n.; Xu, Y.-j.; Zhang, Z.-x.; Cao, Y.; Tang, Y.-j.; Ye, T.; Du, C.-l. 2006: Effects of recombinant adeno-virus vector carrying interleukin-5 antisense on the expression of interleukin-5 mRNA and protein in CD4+ T lymphocytes of asthmatic rats Zhonghua Nei Ke Za Zhi 45(4): 298-301
Sun, R.X.; Gennaro, C.; Rocco, S.; Gu, Z.J.; Klein, B. 1997: Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity European Cytokine Network 8(1): 51-56